Genmab has reduced the fair value of the Brooklyn Park, MN, facility it has been trying to sell for the last few years from $58m to zero. The company will now enter into an aggressive sales process with the aim of closing a transaction in Q1 2013.
Pharma Bio Source
Thursday, 20 December 2012
Genmab desperate to sell
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment